Css LLC Takeda Pharmaceutical CO LTD Put Options Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $82,750 - $93,200	-5,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $1.53 Million - $1.82 Million	-91,300 Reduced 94.81%	5,000 $91,000
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $76,950 - $94,850	5,000 Added 5.48%	96,300 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $171,000 - $191,900	-10,000 Reduced 9.87%	91,300 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $145,900 - $195,000	10,000 Added 10.95%	101,300 $1.82 Million

Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $766,878 - $1.2 Million	58,900 Added 181.79%	91,300 $1.39 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $422,000 - $520,749	-25,000 Reduced 43.55%	32,400 $639,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $67,830 - $75,558	-4,200 Reduced 6.82%	57,400 $987,000
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $484,135 - $598,308	29,200 Added 90.12%	61,600 $1.09 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $541,080 - $697,248	32,400 New	32,400 $660,000

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.